References
- Adess M, Eisner R, Nand S, Godwin J, Messmore HL Jr, Wehrmacher WH (2006). Thromboembolism in cancer patients: pathogenesis and treatment. Clin Appl Thromb Hemost, 12, 254-66. https://doi.org/10.1177/1076029606291432
- Al Diab AI (2010). Cancer-related venous thromboembolism: insight into underestimated risk factors. Hematol Oncol Stem Cell Ther, 3, 191-5. https://doi.org/10.5144/1658-3876.2010.191
- Aliustaoglu M, Bilici A, Seker M, et al (2010). The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterology, 57, 640-5.
- Alkim H, Ayaz S, Sasmaz N, Oguz P, Sahin B (2012). Hemostatic abnormalities in cirrhosis and tumor-related portal vein thrombosis. Clin Appl Thromb Hemost, 18, 409-15. https://doi.org/10.1177/1076029611427900
- Barbier L, Turrini O, Sarran A, Delpero JR (2010). Pancreatic endocrine tumor with neoplastic venous thrombus and bilobar liver metastasis. A case report. J Visc Surg, 147, 58-62. https://doi.org/10.1016/j.jviscsurg.2010.02.006
- Becouarn Y, Senesse P, Thezenas S, et al (2007). A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Federation Nationale des Centres de Lutte Contre le Cancer. Ann Oncol, 18, 2000-5. https://doi.org/10.1093/annonc/mdm379
- Biino G, Portas L, Murgia F, et al (2012). A population-based study of an Italian genetic isolate reveals that mean platelet volume is not a risk factor for thrombosis. Thromb Res, 129, 8-13.
- Braekkan SK, Mathiesen EB, Njolstad I, et al (2012). Mean platelet volume is a risk factor for venous thromboembolism: the tromso study. J Thromb Haemost, 8, 157-62.
- Burris HA, 3rd, Moore MJ, Andersen J, et al (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 15, 2403-13.
- Canan A, Halicioglu SS, Gurel S (2012). Mean platelet volume and D-dimer in patients with suspected deep venous thrombosis. J Thromb Thrombolysis, 34, 283-7. https://doi.org/10.1007/s11239-012-0746-2
- Canyilmaz E, Serdar L, Uslu GH, et al (2013). Evaluation of prognostic factors and survival results in pancreatic carcinomas in Turkey. Asian Pac J Cancer Prev, 14, 6573-8. https://doi.org/10.7314/APJCP.2013.14.11.6573
- Cheung R (2013). Racial and social economic factors impact on the cause specific survival of pancreatic cancer: a SEER survey. Asian Pac J Cancer Prev, 14, 159-63. https://doi.org/10.7314/APJCP.2013.14.1.159
- Chew HK, Wun T, Harvey D, Zhou H, White RH (2006). Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med, 166, 458-64. https://doi.org/10.1001/archinte.166.4.458
- Chu SG, Becker RC, Berger PB, et al (2012). Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost, 8, 148-56.
- Geer RJ, Brennan MF (1993). Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg, 165, 68. https://doi.org/10.1016/S0002-9610(05)80406-4
- Habib M, Saif MW (2013). Thromboembolism and anticoagulation in pancreatic cancer. JOP, 14, 135-7.
- Heit JA, SilversteinMD, Mohr DN, et al (2000). Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med, 160, 809-15. https://doi.org/10.1001/archinte.160.6.809
- Hutten BA, Prins MH, Gent M, et al (2000). Incidence of recurrent thromboembolic and bleeding complications among patients with thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol, 18, 3078.
- Karaman K, Bostanci EB, Aksoy E, et al (2011). The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. Eur J Intern Med, 22, 95-8.
- Kurt M, Onal IK, Sayilir AY, et al (2012). The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology, 59, 1580-2.
- Lee JC, J Ro YS, Hyejin C (2013). Venous thromboemboembolism in patients with pancreatic cancer: Incidence and effect on survival in east Asian ethnic groups. J Clin Oncol, 30, 151.
- Lip GY, Chin BS, Blann AD (2002). Cancer and the prothrombotic state. Lancet Oncol, 3, 27. https://doi.org/10.1016/S1470-2045(01)00619-2
- Liu XM, Liu FH, Tang Y, Li Q (2012). MTHFR C677T polymorphism and pancreatic cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 3763-6. https://doi.org/10.7314/APJCP.2012.13.8.3763
- Mutlu H, Artis TA, Erden A, Akca Z (2012). Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis. Clin Appl Thromb Hemost, 19, 331-3.
- Norsa' adah B, Nur-Zafira A, Knight A (2012). Pancreatic cancer in Universiti Sains Malaysia Hospital: a retrospective review of years 2001-2008. Asian Pac J Cancer Prev, 13, 2857-60. https://doi.org/10.7314/APJCP.2012.13.6.2857
- Porta M, Fabregat X, Malats N, et al (2005). Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol, 7, 189-97. https://doi.org/10.1007/BF02712816
- Sgouros J, Maraveyas A (2008). Excess premature (3-month) mortality in advanced pancreatic cancer could be related to fatal vascular thromboembolic events. A hypothesis based on a systematic review of phase III chemotherapy studies in advanced pancreatic cancer. Acta Oncol, 47, 337-46. https://doi.org/10.1080/02841860701687267
- Shaib W, Denq Y, Zilterman D, Lundberq B, Saif MW (2010). Assessing risk and mortality of venous thromboembolism in pancreatic cancer patients. Anticancer Res, 30, 4261-4.
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, CA Cancer J Clin, 63, 11. https://doi.org/10.3322/caac.21166
- Streiff MB (2011). Anticoagulation in the management of venous thromboembolism in the cancer patient. J Thromb Thrombolysis, 31, 282-94. https://doi.org/10.1007/s11239-011-0562-0
- Trede M, Schwall G, Saeger HD (1990). Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg, 211, 447. https://doi.org/10.1097/00000658-199004000-00011
- Zhang JF, Hua R, Sun YW, et al (2013). Influence of perineural invasion on survival and recurrence in patients with resected pancreatic cancer. Asian Pac J Cancer Prev, 14, 5133-9. https://doi.org/10.7314/APJCP.2013.14.9.5133
Cited by
- Can Head and Neck Cancers Be Detected with Mean Platelet Volume? vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7045
- Relationships Between C-Kit Expression and Mean Platelet Volume in Benign, Preneoplastic and Neoplastic Endometrium vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1495
- Increased UGT1A3 and UGT1A7 Expression is Associated with Pancreatic Cancer vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1651
- Thromboembolisms in Advanced Pancreatic Cancer vol.46, pp.8, 2017, https://doi.org/10.1097/MPA.0000000000000889
- Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer pp.17526981, 2017, https://doi.org/10.1111/crj.12605
- Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer vol.0, pp.0, 2018, https://doi.org/10.1515/cclm-2018-0016